Tarzana, CA, United States of America

Anastasia Lomova

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anastasia Lomova. Retrieved from https://idiyas.com/inventor/anastasia-lomova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Gene Editing by Anastasia Lomova

Introduction

Anastasia Lomova is a pioneering inventor based in Tarzana, California. She has made significant contributions to the field of gene editing, particularly in addressing monogenic disorders. Her work focuses on innovative solutions that have the potential to transform medical treatments.

Latest Patents

Anastasia holds a patent titled "Gene Editing of Monogenic Disorders in Human Hematopoietic Stem Cells -- Correction of X-Linked Agammaglobulinemia (XLA)." This patent represents a crucial advancement in the treatment of genetic disorders, showcasing her expertise and dedication to improving human health.

Career Highlights

Anastasia is affiliated with the University of California, where she conducts her research and development. Her academic background and commitment to innovation have positioned her as a leader in her field. With 1 patent to her name, she continues to push the boundaries of what is possible in gene therapy.

Collaborations

Anastasia has collaborated with notable researchers, including Donald B. Kohn and Caroline Y. Kuo. These partnerships have enhanced her research efforts and contributed to the advancement of gene editing technologies.

Conclusion

Anastasia Lomova's work in gene editing exemplifies the potential of innovative solutions to address complex medical challenges. Her contributions are paving the way for future advancements in the treatment of genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…